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Orthostatic hypotension (OH) is a common condition in 
older persons. According to the 2011 criteria, OH is defined 
by a sustained reduction of systolic blood pressure of 20 
mmHg or a 10 mmHg-fall of diastolic blood pressure.
[1]
 Its 
prevalence increases with age and according to a recent 
systematic review the pooled prevalence in community 
dwelling older people is 22.2%.
[2]
 Although OH is largely 
explained by concurrent clinical conditions (in particular, 
hypertension, diabetes, malnutrition, vascular 
encephalopathy, anemia, Parkinson’s disease)[3], aging per 
se determines a series of physiological dysfunctions 
potentially representing its biological substratum (e.g., 
reduction in baroreflex-mediated cardiovascular function, 
altered salt and water balance at renal level, impaired 
cardiac diastolic filling). It is also noteworthy that 
age-related changes in pharmacokinetic and 
pharmacodynamic mechanisms of drugs (especially in the 
context of polypharmacy) also increase the risk of OH. 

 
OH is often asymptomatic. Therefore, the individual may 
remain unaware of OH until a certain stressor suddenly 
exposes it (frequently causing major health consequences 
for the person, such as falls and traumatic injuries). 
Even if research studies exist to evaluate the prevalence 
of OH in community-dwelling people, to the best of our 
knowledge the prevalence of diagnosed OH in routine 
clinical practice in an outpatient setting has never been 
evaluated so far. Our aim was to measure it and compare it 
to what reported by studies conducted for research purpose. 
It was conducted a retrospective analysis of outpatients 
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consequently afferent to a tertiary hospital in Milan for 
memory complaints, functional evaluations or 
comprehensive geriatric assessments during the years 
2011-2014. Ethical approval was not required for this study 
in accordance with the institutional guidelines.  
The following variables characterizing the patients were 
retrieved from medical charts: age, gender, Mini Mental 
State Examination (MMSE), Activity of Daily Living 
(ADL), Instrumental ADL (IADL), Performance Oriented 
Mobility Assessment (POMA), symptoms possibly related 
to OH (i.e., dizziness, light-headedness, weakness, nausea, 
paracervical pain, confusion, speech alterations, visual 
impairment), comorbidities associated with OH (i.e., vomit, 
diarrhea, fluid restriction, other causes of dehydration, 
anemia, aortic stenosis, bradyarrhythmia, hypertension, 
diabetes, chronic kidney disease, heart failure, Parkinson’s 
disease, Lewy’s bodies dementia, amyloidosis, neoplasia, 
potus, cobalamin deficit, multinfartual encephalopathy, 
immobility), and drugs potentially causing OH (i.e., 
diuretics, sympatholytic agents, vasodilators, 
antidepressants, antihypertensive medications, 
anti-Parkinson’s disease drugs). Patients were divided into 
three groups: with OH, not diagnosed with OH but reporting 
suggestive symptoms, not diagnosed with OH and with no 
symptoms.  
Shapiro Wilk test was used to assess the distribution of 
the variables. Categorical variables were compared with 
Fisher exact test and quantitative variables with Kruskal- 
Wallis test. Statistical analyses were performed with Stata 
15 (StataCorp. Stata Statistical Software: Release 13. 
College Station, TX: StataCorp LP. 2017). 
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Among the 465 patients, only 14 (3%) were diagnosed  
Table 1.  Main characteristics of the population. 
 
OH diagnosis 
Not OH diagnosis 
P 
 Symptomatic Asymptomatic 
Number of patients 14 164 287  
Age, median (IQR) 83.5 (8285) 82 (7785.5) 81 (7787) 0.34 
Gender male 4 (28.6%) 56 (34.1%) 93 (32.4%) 0.89 
MMSE, median (IQR) 26 (2327) 25 (2228) 26 (2128) 0.96 
ADL, median (IQR) 5 (45) 4 (35) 5 (36) 0.21 
IADL, median (IQR) 5.5 (3.57) 3 (16) 3 (16) 0.2 
POMA, median (IQR) 20 (822) 13 (1017) 16 (1123) 0.001 
Symptoms     
dizziness 3 (21.4%) 41 (25.1%) 0 (0%) N.A. 
lightheadness 1 (7.1%) 14 (8.6%) 0 (0%) N.A. 
weakness 3 (21.4%) 72 (44.2%) 0 (0%) N.A. 
nausea 0 (0%) 5 (3.1%) 0 (0%) N.A. 
paracervical pain 0 (0%) 22 (13.5%) 0 (0%) N.A. 
confusion 4 (28.6%) 37 (22.7%) 0 (0%) N.A. 
speech alterations 1 (7.1%) 26 (16%) 0 (0%) N.A. 
visual impairment 1 (7.1%) 21 (12.9%) 0 (0%) N.A. 
Comorbidies     
vomit 0 (0%) 6 (3.7%) 2 (0.9%) 0.15 
diarrhea 0 (0%) 3 (1.8%) 2 (0.9%) 0.71 
fluid restriction 1 (7.1%) 2 (1.2%) 0 (0%) 0.02 
other causes of dehydration 0 (0%) 2 (1.2%) 0 (0%) 0.24 
anemia 4 (36.4%) 34 (26%) 37 (19.8%) 0.25 
aortic stenosis 0 (0%) 8 (5.5%) 24 (8.7%) 0.4 
bradyarrhythmia 2 (14.3%) 17 (10.6%) 26 (9.1%) 0.63 
hypertension 6 (42.9%) 131 (79.9%) 202 (70.4%) 0.004 
diabetes 2 (14.3%) 26 (15.8%) 54 (18.8%) 0.75 
CKD 2 (14.3%) 21 (14.1%) 42 (15.2%) 0.97 
cardiac insufficiency 2 (14.3%) 24 (15%) 49 (17.2%) 0.88 
Parkinson disease 0 (0%) 3 (1.8%) 11 (3.8%) 0.53 
Lewy bodies dementia 0 (0%) 2 (1.2%) 1 (0.3%) 0.36 
amyloidosis 0 (0%) 0 (0%) 1 (0.35%) 1 
neoplasia 2 (14.3%) 27 (16.5%) 58 (20.2%) 0.63 
potus 3 (25%) 41 (33.1%) 47 (19.1%) 0.01 
cobalamin deficit 0 (0%) 9 (15.8%) 15 (9.1%) 0.2 
multinfartual encephalopathy 5 (38.5%) 49 (35.2%) 95 (37.5%) 0.89 
immobility 0 (0%) 3 (1.9%) 3 (1.1%) 0.73 
Drugs     
number of drugs, median (IQR) 5 (36) 6 (37) 6 (38) 0.57 
diuretics 5 (35.7%) 66 (40.5%) 115 (40.5%) 0.97 
sympatholytic 6 (42.9%) 48 (29.5%) 116 (41%) 0.04 
vasodilators 4 (28.6%) 41 (25.1%) 71 (25%) 0.94 
antidepressants 5 (35.7%) 36 (21.9%) 60 (21.1%) 0.42 
antihypertensive 8 (57.1%) 107 (65.6%) 175 (62.1%) 0.66 
antiparkinson 1 (7.1%) 4 (2.4%) 9 (3.2%) 0.39 
ADL: Activity of Daily Living; CKD: chronic kidney disease; IADL: Instrumental ADL; IQR: inter quartile range; MMSE: Mini Mental State Examination; 
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POMA: Performance Oriented Mobility Assessment. 
with OH. Overall the sample was old (mean age 81.3 ± 6.8), 
with a greater prevalence of female (314, 66.4%), without 
significant cognitive impairment (mean MMSE 24 ± 5), 
with a moderate functional decline (mean ADL 4 ± 1.8, 
mean IADL 3.7 ± 2.6), with an elevated risk of falling 
(mean POMA 15.2 ± 6.9) and polypharmacy (5.8 ± 3.3).  
Table 1 illustrates the main characteristics of the three 
groups.. Amidst people not diagnosed with OH 164 persons 
complained about symptoms potentially suggestive of it and 
were more likely to present potus, hypertension, and poor 
POMA results than the asymptomatic ones (all P < 0.05). 
The prevalence of OH found in our sample (3%) is 
substantially lower than what reported in literature (22.2%). 
Considering the main characteristics of the patients  it is 
difficult to think that OH prevalence could really be so low. 
Indeed, the prevalence of OH tends to increase with age,
[4]
 
chronic diseases
[5]
 and polypharmacy.
[6]
 It is true that the 
lack of procedural consistency in measuring OH could 
partially explain the low detected prevalence. The take-over 
could have been influenced by the incorrect position of the 
sphygmomanometer, the use of electronical devices, the 
variable level of orthostatic stress and the different time of 
lying down and standing before orthostatic measurements 
were obtained. This last point is particularly critical since 
the current guidelines
[1]
 lack the explicit timing information 
needed to define a sustained OH response, thus causing an 
extreme variability in OH measurements also in clinical 
studies. Moreover, OH is affected by diurnal variation and 
is less detectable in the afternoon.  
Our study suggests that OH is seldom sought in clinical 
practice, even if guidelines recommend the screening of 
postural variations of blood pressure in older people 
regardless the presence of postural symptoms.
[7]
 This 
malpractice can lead to adverse and expensive 
consequences.  
OH has been linked to increased mortality, 
cardiovascular diseases, cognitive impairment, falls and 
hospitalizations;
[8]
 its detection could reduce the chance of 
inappropriate selection of the drug classes for older patients 
and therefore it assumes paramount importance under a 
public health perspective since OH consequences can rise 
the health care expenditure and significantly impact the life 
quality of older people.
[9,10]
 
Unfortunately, the presence of multiple co-morbid condi-
tions and the non-specificity of signs and symptoms make 
the OH identification quite challenging. It is necessary to 
promote its detection by simply adhering to the gold 
standard recommendations for the blood pressure measure-
ment in the clinical setting.
[7]
  
Exploiting a non-invasive procedure to assess postural 
variation of blood pressure should be supposed to be part of 
the normal routine. The lack of time frequently complained 
by physicians in performing the screening for OH, is not an 
excuse. 
On the other hand, public health authorities should start 
considering that the proper management of older persons 
cannot be compressed in the fewer and fewer minutes of 
evaluation conducted in the busy outpatient clinics.  
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